My Newborn Son's Roth IRA And The Fabulous Wonders Of Compounding

Spire Global Stock: A Buy After The Likely Reverse Split

AbCellera Biologics: TCE Program Alone Could Be Worth More Than The Current Market Cap

Coda Octopus: DAVD To Drive Significant Growth, Stock Still Undervalued After 50% Jump

Confounded's Complete All-Weather Portfolio Revealed

SVB Financial's Collapse Is Poised To Help, Not Hurt The Big Banks

OmniAb: Legitimate Competition To AbCellera In Antibody Discovery

Sono-Tek Corp: A Micro-Cap Company Ready To Surf The Semi And Alt Energy Wave

Stock Based Compensation: The Dilution Potential Of The Worst Offenders

AbCellera Biologics: My Updated Current Valuation Estimate

Stock Based Compensation: A List Of The Worst Offenders And A Few Of The Best

Dominion Energy: It May Be Woke, But It Won't Go Broke

AbCellera Biologics: Q3 Commentary - Moving Up The Value Stack

Confounded's Complete Aggressive Growth Portfolio - Narrowly Avoiding Catastrophe

Spire Global: Profitability Or Bust

Fed Induced Carnage - A Shopping List For The Brave

Alexandria Real Estate: The Stock Market Has Lost Its Mind, I'm Buying

Coda Octopus: Solid Progress In Defense Applications Evident In Q3 Results

Charles River Laboratories: A 'Picks And Shovels' Biomedical Play, Now Attractively Priced

Amerco: An Effective Monopoly To Hold For The Next Decade

AbCellera Biologics: COVID Antibody Set To Provide Continued Funding

Perimeter Solutions: A Moat Full Of Alligators In The Aerial Retard Market

Cedar Fair: Recession And Inflation Do Not Worry Me One Bit

Intel: National Security Requires Success - CHIPS Act Passage Is Only A Matter Of Time

Hanesbrands: I See Deep Value In Recession Resistant Apparel